
Pharma Pulse: Eli Lilly’s Employer Connect Platform and Tandem Mobi Android Integration
In today’s Pharma Pulse, Eli Lilly has launched the Employer Connect platform broadening access to Zepbound for U.S. workers, while Tandem Diabetes expands the reach of its Mobi insulin pump to Android smartphones.
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast in which we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines.
- Eli Lilly has
launched Employer Connect , a platform linking employers with over fifteen independent administrators to expand access to the obesity medication Zepbound. The system offers cost-transparent options, aiming to close coverage gaps for the one hundred million US adults living with obesity. - In other news, Tandem Diabetes is
expanding its Mobi insulin pump to Android users . The world’s smallest durable automated delivery system is now compatible with select Pixel and Galaxy models, allowing users to control their insulin discreetly from their phones while achieving a reported 79% time-in-range.
That’s it for this episode of Pharma Pulse. For more insights on trends transforming pharmaceutical access and care delivery, visit
Thanks for listening—until next time, stay well and stay informed.
You can catch Pharma Pulse directly on




